Short Report – Special Collection: African Health Systems

A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir

Junaid Omar, Izak Loftus, Nabeelah Vallie, Richard B. Whitmore, Gaironesa Solomon, Michelle Powell, Samela Mniki, Mosedi Namane
African Journal of Primary Health Care & Family Medicine | Vol 13, No 1 | a3088 | DOI: https://doi.org/10.4102/phcfm.v13i1.3088 | © 2021 Junaid Omar, Izak Loftus, Nabeelah Vallie, Richard B. Whitmore, Gaironesa Solomon, Michelle Powell, Samela Mniki, Mosedi Namane | This work is licensed under CC Attribution 4.0
Submitted: 14 June 2021 | Published: 30 September 2021

About the author(s)

Junaid Omar, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa
Izak Loftus, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa
Nabeelah Vallie, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa
Richard B. Whitmore, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa
Gaironesa Solomon, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa
Michelle Powell, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa
Samela Mniki, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa
Mosedi Namane, Vanguard Community Health Centre, Western Cape Department of Health, Cape Town, South Africa; and, Department of Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa


Share this article

Bookmark and Share

Abstract

A group of Vanguard Community Health Centre doctors embarked on a Health System’s Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.

Keywords

HIV; renal protection; health system improvement; South Africa; Dolutegravir

Metrics

Total abstract views: 794
Total article views: 830


Crossref Citations

No related citations found.